Skip to Content

US: AstraZeneca may have used outdated info in vaccine trial

AstraZeneca-Vaccine

WASHINGTON (AP) — U.S. federal health officials say results from a U.S. trial of AstraZeneca’s COVID-19 vaccine may have used “outdated information."

The Data and Safety Monitoring Board said in a statement that it was concerned that AstraZeneca may have provided an incomplete view of the efficacy data.

AstraZeneca reported Monday that its COVID-19 vaccine provided strong protection among adults of all ages in a long-anticipated U.S. study, a finding that could help rebuild public confidence in the shot around the world and move it a step closer to clearance in the U.S.

Author Profile Photo

Associated Press

Skip to content